Deliver Your News to the World

CIGNA Recognized by CEO Roundtable for Preventing Cancer


PHILADELPHIA.- CIGNA today was recognized for its work to improve the health of its employees and reduce their risks of cancer. The company received the CEO Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer, a non-profit organization of cancer-fighting CEOs from major American companies. This distinction is given only after a company meets or exceeds the rigorous requirements set out by the CEO Roundtable on Cancer.

“As a leading health service company, CIGNA is proud to be a strong force in the fight against cancer,” said H. Edward Hanway, chairman and chief executive officer of CIGNA Corporation. “This accreditation is an important recognition of our ongoing contributions toward improving health, well-being and security for our own employees and all the people we serve.”

The CEO Cancer Gold Standard calls for companies to evaluate their benefits and environment and take extensive, concrete actions in health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by encouraging physical activity, healthy diet and nutrition; promoting cancer detection at its earliest stages; discouraging tobacco use; and providing access to quality cancer care, including the availability of clinical trials. These types of actions are inherent in CIGNA’s Healthy Life strategy for improving employee health.

“CIGNA’s success and reputation has been built on more than 200 years of commitment to healthy individuals and healthy communities,” said William C. Weldon, chairman and chief executive officer of Johnson & Johnson, who chairs the CEO Roundtable on Cancer. “This CEO Cancer Gold Standard certification acknowledges CIGNA’s leadership in demonstrating that its commitment begins first and foremost with providing for the health and well-being of its employees and family members.”

CIGNA is the 30th organization to achieve Gold Standard accreditation since the program’s inception in 2006. With this milestone, CIGNA joins other companies such as Pfizer, AstraZeneca and Johnson & Johnson as recognized leaders doing their part to help reduce cancer risks, improve detection and ensure access to quality health care for cancer treatment. Statistics show that efforts by companies like these can have an impact on cancer, as The American Cancer Society estimates that at least half of all cancer deaths can be avoided.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.